Variant report
Variant | nsv528405 |
---|---|
Chromosome Location | chr12:103896595-103901502 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:376)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:103343745..103344702-chr12:103897389..103898552,4 | MCF-7 | breast: | |
2 | chr12:103719744..103720561-chr12:103897421..103897994,2 | MCF-7 | breast: | |
3 | chr12:103342772..103343296-chr12:103897586..103898267,2 | MCF-7 | breast: | |
4 | chr12:103794502..103795818-chr12:103897463..103898386,6 | MCF-7 | breast: | |
5 | chr12:103900419..103903095-chr12:103904941..103907379,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C12orf42-4 | chr12:103899762-103899952 | NONHSAT030376 |
2 | lnc-C12orf42-4 | chr12:103899189-103899392 | NONHSAT030376 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000257415 | TF binding region |
ENSG00000257994 | TF binding region |
ENSG00000171759 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17034027 | chr12:103896595-103896596 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs17034029 | chr12:103896685-103896686 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs193125860 | chr12:103896750-103896751 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557383410 | chr12:103896751-103896752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs577068303 | chr12:103896761-103896762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs369515643 | chr12:103896811-103896812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs577326367 | chr12:103896852-103896853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs185618863 | chr12:103896868-103896869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189330175 | chr12:103896914-103896915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573606645 | chr12:103896949-103896950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544468334 | chr12:103896960-103896961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138079500 | chr12:103896971-103896972 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560033373 | chr12:103896998-103896999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573352948 | chr12:103897086-103897087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545621963 | chr12:103897087-103897088 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7139385 | chr12:103897139-103897140 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142693695 | chr12:103897211-103897212 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550968475 | chr12:103897225-103897226 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561104103 | chr12:103897229-103897230 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs530142613 | chr12:103897248-103897249 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548998404 | chr12:103897268-103897269 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs111653960 | chr12:103897269-103897270 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs79570689 | chr12:103897287-103897288 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142775778 | chr12:103897293-103897294 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs570982056 | chr12:103897294-103897295 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191411481 | chr12:103897314-103897315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556670099 | chr12:103897315-103897316 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs75356146 | chr12:103897360-103897361 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559706667 | chr12:103897466-103897467 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs536289995 | chr12:103897470-103897471 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs144260415 | chr12:103897482-103897483 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs573493118 | chr12:103897508-103897509 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs545586990 | chr12:103897509-103897510 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs554258842 | chr12:103897546-103897547 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs575938723 | chr12:103897547-103897548 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs544703802 | chr12:103897558-103897559 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs529676185 | chr12:103897579-103897580 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs148755547 | chr12:103897581-103897582 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs574708085 | chr12:103897582-103897583 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs540629771 | chr12:103897613-103897614 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs375173915 | chr12:103897630-103897631 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs117820907 | chr12:103897638-103897639 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs528391702 | chr12:103897723-103897724 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs559804786 | chr12:103897777-103897778 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs75320294 | chr12:103897778-103897779 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs141515749 | chr12:103897785-103897786 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs114496824 | chr12:103897880-103897881 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs184185687 | chr12:103897885-103897886 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs567356490 | chr12:103897893-103897894 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs140165975 | chr12:103897894-103897895 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 16751803 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 16397240 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Neurocytoma | 17123091 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:103893600-103897200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr12:103893600-103897200 | Weak transcription | HMEC | breast |
3 | chr12:103893600-103897400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr12:103894000-103898000 | Weak transcription | GM12878-XiMat | blood |
5 | chr12:103895800-103898200 | Enhancers | Thymus | Thymus |
6 | chr12:103897200-103897400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr12:103897200-103897800 | Enhancers | Fetal Thymus | thymus |
8 | chr12:103897200-103898000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr12:103897200-103900000 | Enhancers | HMEC | breast |
10 | chr12:103897400-103898600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr12:103897400-103899600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
12 | chr12:103897600-103898000 | Enhancers | Primary B cells from peripheral blood | blood |
13 | chr12:103898000-103898400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr12:103898000-103898600 | Enhancers | GM12878-XiMat | blood |
15 | chr12:103898000-103899000 | Weak transcription | Primary B cells from peripheral blood | blood |
16 | chr12:103898400-103899800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr12:103898600-103899800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
18 | chr12:103898600-103900000 | Flanking Active TSS | GM12878-XiMat | blood |
19 | chr12:103898600-103900000 | Enhancers | NHEK | skin |
20 | chr12:103899000-103899200 | Enhancers | Primary B cells from peripheral blood | blood |
21 | chr12:103900000-103900200 | Enhancers | GM12878-XiMat | blood |